New horizons in one of ophthalmology’s challenges: fungal keratitis

References

• Ibrahim MM, Vanini R, Ibrahim FM et al. Epidemiologic aspects and clinical outcome of fungal keratitis in southeastern Brazil. Eur. J. Ophthalmol.19(3), 355–361 (2009).
   PubMedGoogle Scholar
• Srinivasan M, Gonzales CA, George C et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br. J. Ophthalmol.81(11), 965–971 (1997).
   PubMed Web of Science ®Google Scholar
• Pepose JS, Wilhelmus KR. Divergent approaches to the management of corneal ulcers. Am. J. Ophthalmol.114(5), 630–632 (1992).
   PubMed Web of Science ®Google Scholar
• Keay LJ, Gower EW, Iovieno A et al. Clinical and microbiological characteristics of fungal keratitis in the United States, 2001–2007: a multicenter study. Ophthalmology118(5), 920–926 (2011).
   PubMed Web of Science ®Google Scholar
• Bharathi MJ, Ramakrishnan R, Meenakshi R et al. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol.14(2), 61–69 (2007).
   PubMed Web of Science ®Google Scholar
• Leck AK, Thomas PA, Hagan M et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br. J. Ophthalmol.86(11), 1211–1215 (2002).
   PubMed Web of Science ®Google Scholar
• Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J.23(4), 275–281 (1997).
   PubMedGoogle Scholar
• Sirikul T, Prabriputaloong T, Smathivat A, Chuck RS, Vongthongsri A. Predisposing factors and etiologic diagnosis of ulcerative keratitis. Cornea27(3), 283–287 (2008).
   PubMedGoogle Scholar
• Foster CS. Fungal keratitis. Infect. Dis. Clin. North Am.6(4), 851–857 (1992).
   PubMed Web of Science ®Google Scholar
• Chin GN, Hyndiuk RA, Kwasny GP, Schultz RO. Keratomycosis in Wisconsin. Am. J. Ophthalmol.79(1), 121–125 (1975).
   PubMed Web of Science ®Google Scholar
• Doughman DJ, Leavenworth NM, Campbell RC, Lindstrom RL. Fungal keratitis at the University of Minnesota: 1971–1981. Trans. Am. Ophthalmol. Soc.80, 235–247 (1982).
   PubMedGoogle Scholar
• Jones DB, Sexton R, Rebell G. Mycotic keratitis in South Florida: a review of thirty-nine cases. Trans. Ophthalmol. Soc. UK89, 781–797 (1970).
   PubMedGoogle Scholar
• Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology101(6), 1005–1013 (1994).
   PubMed Web of Science ®Google Scholar
• Schein OD, Glynn RJ, Poggio EC, Seddon JM, Kenyon KR. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case–control study. Microbial Keratitis Study Group. N. Engl. J. Med.321(12), 773–778 (1989).
   PubMed Web of Science ®Google Scholar
• Poggio EC, Glynn RJ, Schein OD et al. The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N. Engl. J. Med.321(12), 779–783 (1989).
   PubMed Web of Science ®Google Scholar
• Gower EW, Keay LJ, Oechsler RA et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology117(12), 2263–2267 (2010).
   PubMed Web of Science ®Google Scholar
• Chang DC, Grant GB, O’Donnell K et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA296(8), 953–963 (2006).
   PubMed Web of Science ®Google Scholar
• Khor WB, Aung T, Saw SM et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA295(24), 2867–2873 (2006).
   PubMed Web of Science ®Google Scholar
• Bullock JD, Elder BL, Khamis HJ, Warwar RE. Effects of time, temperature, and storage container on the growth of Fusarium species: implications for the worldwide Fusarium keratitis epidemic of 2004–2006. Arch. Ophthalmol.129(2), 133–136 (2011).
   PubMed Web of Science ®Google Scholar
• Jones BR. Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. Am. J. Ophthalmol.79(5), 719–751 (1975).
   PubMed Web of Science ®Google Scholar
• Dahlgren MA, Lingappan A, Wilhelmus KR. The clinical diagnosis of microbial keratitis. Am. J. Ophthalmol.143(6), 940–944 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas PA, Leck AK, Myatt M. Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. Br. J. Ophthalmol.89(12), 1554–1558 (2005).
   PubMed Web of Science ®Google Scholar
• Prajna NV, Mascarenhas J, Krishnan T et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch. Ophthalmol.128(6), 672–678 (2010).
   PubMedGoogle Scholar
• Demers PE. Corneal biopsy. Tech. Ophthalmol.1(2), 92–97 (2003).
   Google Scholar
• Sharma S, Kunimoto DY, Gopinathan U et al. Evaluation of corneal scraping smear examination methods in the diagnosis of bacterial and fungal keratitis: a survey of eight years of laboratory experience. Cornea21(7), 643–647 (2002).
   PubMed Web of Science ®Google Scholar
• McLeod SD, Kolahdouz-Isfahani A, Rostamian K et al. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology103(1), 23–28 (1996).
   PubMed Web of Science ®Google Scholar
• Zhang W, Yang H, Jiang L, Han L, Wang L. Use of potassium hydroxide, giemsa and calcofluor white staining techniques in the microscopic evaluation of corneal scrapings for diagnosis of fungal keratitis. J. Int. Med. Res.38(6), 1961–1967 (2010).
   PubMed Web of Science ®Google Scholar
• Sharma S, Silverberg M, Mehta P et al. Early diagnosis of mycotic keratitis: predictive value of potassium hydroxide preparation. Indian J. Ophthalmol.46(1), 31–35 (1998).
   PubMedGoogle Scholar
• Chowdhary A, Singh K. Spectrum of fungal keratitis in North India. Cornea24(1), 8–15 (2005).
   PubMed Web of Science ®Google Scholar
• Panda A, Sharma N, Das G, Kumar N, Satpathy G. Mycotic keratitis in children: epidemiologic and microbiologic evaluation. Cornea16(3), 295–299 (1997).
   PubMed Web of Science ®Google Scholar
• Vengayil S, Panda A, Satpathy G et al. Polymerase chain reaction-guided diagnosis of mycotic keratitis: a prospective evaluation of its efficacy and limitations. Invest. Ophthalmol. Vis. Sci.50(1), 152–156 (2009).
   PubMedGoogle Scholar
• Gaudio PA, Gopinathan U, Sangwan V, Hughes TE. Polymerase chain reaction based detection of fungi in infected corneas. Br. J. Ophthalmol.86(7), 755–760 (2002).
   PubMedGoogle Scholar
• Pierard GE, Arrese JE, De Doncker P, Pierard-Franchimont C. Present and potential diagnostic techniques in onychomycosis. J. Am. Acad. Dermatol.34(2 Pt 1), 273–277 (1996).
   PubMed Web of Science ®Google Scholar
• Thomas PA, Kaliamurthy J, Jesudasan CA, Geraldine P. Use of chlorazol black E mounts of corneal scrapes for diagnosis of filamentous fungal keratitis. Am. J. Ophthalmol.145(6), 971–976 (2008).
   PubMed Web of Science ®Google Scholar
• Das S, Sharma S, Kar S et al. Is inclusion of sabouraud dextrose agar essential for the laboratory diagnosis of fungal keratitis? Indian J. Ophthalmol.58(4), 281–286 (2010).
   PubMed Web of Science ®Google Scholar
• McGinnis M. Laboratory handbook of medical mycology. Academic Press, NY, USA (1980).
   Google Scholar
• Dursun D, Fernandez V, Miller D, Alfonso EC. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea22(4), 300–303 (2003).
   PubMed Web of Science ®Google Scholar
• Vaddavalli PK, Garg P, Sharma S et al. Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis. Ophthalmology118(1), 29–35 (2011).
   PubMed Web of Science ®Google Scholar
• Ritterband DC, Seedor JA, Shah MK, Koplin RS, McCormick SA. Fungal keratitis at the New York eye and ear infirmary. Cornea25(3), 264–267 (2006).
   PubMed Web of Science ®Google Scholar
• Ando N, Takatori K. Fungal flora of the conjunctival sac. Am. J. Ophthalmol.94(1), 67–74 (1982).
   PubMed Web of Science ®Google Scholar
• Ainley R, Smith B. Fungal flora of the conjunctival sac in healthy and diseased eyes. Br. J. Ophthalmol.49(10), 505–515 (1965).
   PubMed Web of Science ®Google Scholar
• Menassa N, Bosshard PP, Kaufmann C et al. Rapid detection of fungal keratitis with DNA-stabilizing FTA filter paper. Invest. Ophthalmol. Vis. Sci.51(4), 1905–1910 (2010).
   PubMed Web of Science ®Google Scholar
• Saini JS, Jain AK, Kumar S et al. Neural network approach to classify infective keratitis. Curr. Eye Res.27(2), 111–116 (2003).
   PubMed Web of Science ®Google Scholar
• Chandna A, Fisher AC, Cunningham I, Stone D, Mitchell M. Pattern recognition of vertical strabismus using an artificial neural network (StrabNet). Strabismus17(4), 131–138 (2009).
   PubMedGoogle Scholar
• Bizios D, Heijl A, Bengtsson B. Trained artificial neural network for glaucoma diagnosis using visual field data: a comparison with conventional algorithms. J. Glaucoma16(1), 20–28 (2007).
   PubMedGoogle Scholar
• Kaiserman I, Rosner M, Pe’er J. Forecasting the prognosis of choroidal melanoma with an artificial neural network. Ophthalmology112(9), 1608 (2005).
   PubMedGoogle Scholar
• Kalavathy CM, Parmar P, Kaliamurthy J et al. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea24(4), 449–452 (2005).
   PubMed Web of Science ®Google Scholar
• Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am. J. Ophthalmol.137(5), 820–825 (2004).
   PubMed Web of Science ®Google Scholar
• O’Day DM. Selection of appropriate antifungal therapy. Cornea6(4), 238–245 (1987).
   PubMed Web of Science ®Google Scholar
• Tu EY, McCartney DL, Beatty RF et al. Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592). Am. J. Ophthalmol.143(2), 222–227 (2007).
   PubMed Web of Science ®Google Scholar
• Gauthier GM, Nork TM, Prince R, Andes D. Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clin. Infect. Dis.41(3), e27–e28 (2005).
   PubMed Web of Science ®Google Scholar
• Vorwerk CK, Tuchen S, Streit F et al. Aqueous humor concentrations of topically administered caspofungin in rabbits. Ophthalmic Res.41(2), 102–105 (2009).
   PubMedGoogle Scholar
• Hurtado-Sarrio M, Duch-Samper A, Cisneros-Lanuza A et al. Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole. Arch. Ophthalmol.128(7), 941–942 (2010).
   PubMedGoogle Scholar
• Matsumoto Y, Murat D, Kojima T, Shimazaki J, Tsubota K. The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br. J. Ophthalmol. DOI: bjo.2010.191734 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Matsumoto Y, Dogru M, Goto E, Fujishima H, Tsubota K. Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review. Cornea24(6), 748–753 (2005).
   PubMed Web of Science ®Google Scholar
• Florcruz NV, Peczon I Jr. Medical interventions for fungal keratitis. Cochrane Database Syst. Rev.1, CD004241 (2008).
   Google Scholar
• Lalitha P, Shapiro BL, Srinivasan M et al. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch. Ophthalmol.125(6), 789–793 (2007).
   PubMed Web of Science ®Google Scholar
• Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br. J. Ophthalmol.92(7), 871–878 (2008).
   PubMed Web of Science ®Google Scholar
• Gao H, Pennesi M, Shah K et al. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans. Am. Ophthalmol. Soc.101, 183–189; discussion 89 (2003).
   PubMedGoogle Scholar
• Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob. Agents Chemother.51(1), 239–244 (2007).
   PubMed Web of Science ®Google Scholar
• Lau D, Fedinands M, Leung L et al. Penetration of voriconazole, 1%, eyedrops into human aqueous humor: a prospective open-label study. Arch. Ophthalmol.126(3), 343–346 (2008).
   PubMedGoogle Scholar
• Prajna NV, John RK, Nirmalan PK, Lalitha P, Srinivasan M. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br. J. Ophthalmol.87(10), 1235–1237 (2003).
   PubMed Web of Science ®Google Scholar
• Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br. J. Ophthalmol.82(8), 919–925 (1998).
   PubMed Web of Science ®Google Scholar
• Perez-Balbuena AL, Vanzzini-Rosano V, Valadez-Virgen Jde J, Campos-Moller X. Fusarium keratitis in Mexico. Cornea28(6), 626–630 (2009).
   PubMed Web of Science ®Google Scholar
• Anane S, Ben Ayed N, Malek I et al. [Keratomycosis in the area of Tunis: epidemiological data, diagnostic and therapeutic modalities]. Ann. Biol. Clin. (Paris)68(4), 441–447 (2010).
   PubMedGoogle Scholar
• Thomas PA. Fungal infections of the cornea. Eye (Lond.)17(8), 852–862 (2003).
   PubMed Web of Science ®Google Scholar
• Li L, Wang Z, Li R, Luo S, Sun X. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Am. J. Ophthalmol.146(5), 724–728 (2008).
   PubMed Web of Science ®Google Scholar
• Prajna NV, Nirmalan PK, Mahalakshmi R, Lalitha P, Srinivasan M. Concurrent use of 5% natamycin and 2% econazole for the management of fungal keratitis. Cornea23(8), 793–796 (2004).
   PubMedGoogle Scholar
• Mahdy RA, Nada WM, Wageh MM et al. Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis. Cutan. Ocul. Toxicol.29(3), 193–197 (2010).
   PubMed Web of Science ®Google Scholar
• Xie L, Dong X, Shi W. Treatment of fungal keratitis by penetrating keratoplasty. Br. J. Ophthalmol.85(9), 1070–1074 (2001).
   PubMed Web of Science ®Google Scholar
• Sharma N, Agarwal P, Sinha R et al. Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series. Br. J. Ophthalmol. DOI: bjo.2010.192815 (2011) (Epub ahead of print).
   Google Scholar
• Siatiri H, Daneshgar F, Siatiri N, Khodabande A. The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis. Cornea30(8), 872–875 (2011).
   PubMed Web of Science ®Google Scholar
• Prakash G, Sharma N, Goel M, Titiyal JS, Vajpayee RB. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am. J. Ophthalmol.146(1), 56–59 (2008).
   PubMed Web of Science ®Google Scholar
• Wei LC, Tsai TC, Tsai HY, Wang CY, Shen YC. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application. Curr. Eye Res.35(7), 573–579 (2010).
   PubMed Web of Science ®Google Scholar
• Garg P, Gopinathan U, Nutheti R, Rao GN. Clinical experience with N-butyl cyanoacrylate tissue adhesive in fungal keratitis. Cornea22(5), 405–408 (2003).
   PubMed Web of Science ®Google Scholar
• Chen HC, Tan HY, Hsiao CH et al. Amniotic membrane transplantation for persistent corneal ulcers and perforations in acute fungal keratitis. Cornea25(5), 564–572 (2006).
   PubMed Web of Science ®Google Scholar
• Bell NP, Karp CL, Alfonso EC, Schiffman J, Miller D. Effects of methylprednisolone and cyclosporine A on fungal growth in vitro. Cornea18(3), 306–313 (1999).
   PubMedGoogle Scholar
• Perry HD, Doshi SJ, Donnenfeld ED, Bai GS. Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis. Cornea21(2), 161–163 (2002).
   PubMed Web of Science ®Google Scholar
• Sinha R, Jhanji V, Verma K et al. Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial. Graefes Arch. Clin. Exp. Ophthalmol.248(8), 1167–1172 (2010).
   PubMedGoogle Scholar
• Price MO, Price FW Jr. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Ophthalmology113(10), 1785–1790 (2006).
   PubMed Web of Science ®Google Scholar
• Qu LJ, Xie LX. Changing indications for lamellar keratoplasty in Shandong, 1993–2008. Chin. Med. J. (Engl.)123(22), 3268–3271 (2010).
   PubMedGoogle Scholar
• Xie L, Shi W, Liu Z, Li S. Lamellar keratoplasty for the treatment of fungal keratitis. Cornea21(1), 33–37 (2002).
   PubMed Web of Science ®Google Scholar
• Hu JZ, Xie LX. [Clinical study on the recurrence of fungal keratitis after lamellar keratoplasty]. Zhonghua Yan Ke Za Zhi.44(2), 111–115 (2008).
   PubMedGoogle Scholar
• Xie L, Zhong W, Shi W, Sun S. Spectrum of fungal keratitis in north China. Ophthalmology113(11), 1943–1948 (2006).
   PubMed Web of Science ®Google Scholar
• Anshu A, Parthasarathy A, Mehta JS, Htoon HM, Tan DT. Outcomes of therapeutic deep lamellar keratoplasty and penetrating keratoplasty for advanced infectious keratitis: a comparative study. Ophthalmology116(4), 615–623 (2009).
   PubMed Web of Science ®Google Scholar